Coronary artery disease (CAD) represents a widespread burden to both individual and
public health, steadily rising across the globe. The current guidelines recommend non …

Coronary artery disease (CAD) is one of the leading causes of morbidity and mortality and it
is responsible for an increasing resource burden. The identification of patients at high risk for …

Aims The combined use of cardiac computed tomography (CT) coronary angiography
(CTCA) and myocardial perfusion imaging allows the non-invasive evaluation of coronary …

Coronary artery disease (CAD) is the leading cause of mortality worldwide, and various
cardiovascular imaging modalities have been introduced for the purpose of diagnosing and …

Coronary artery disease (CAD) continues to be a leading cause of morbidity and mortality
worldwide. Although invasive coronary angiography has previously been the gold standard …

Despite advances in the pharmacologic and interventional treatment of coronary artery
disease (CAD), atherosclerosis remains the leading cause of death in Western societies. X …

Coronary artery disease (CAD) remains one of the leading causes of morbidity and mortality
worldwide. Moreover, the disease is reaching endemic proportions and will put an …

Myocardial perfusion imaging (MPI) has been a valuable diagnostic and prognosticating tool
for decades, but recently it has been challenged by the growing evidence about either …

Cardiac computed tomography (CT) has emerged as a noninvasive modality for the
assessment of coronary artery disease (CAD), and has been rapidly integrated into clinical …

The American Heart Association 1 estimates that 92.1 million US adults have some form of
cardiovascular disease (CVD). By 2030, CVD will affect nearly half of the US population …